![Jing Jiang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jing Jiang
Directeur/Bestuurslid bij Wuxi Shenrui Bio-Pharmaceuticals Co., Ltd.
Oorsprong van het eerstegraads netwerk van Jing Jiang
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Wuxi Shenrui Bio-Pharmaceuticals Co., Ltd.
![]() Wuxi Shenrui Bio-Pharmaceuticals Co., Ltd. Medical SpecialtiesHealth Technology Wuxi Shenrui Bio-Pharmaceuticals Co., Ltd. is a private company that manufactures medical equipment. The company is based in Wuxi, China. The Chinese company was founded in 1999. The CEO is Qing Song Sheng.
5
| Private Company | Medical Specialties | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jing Jiang via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
GEMPHARMATECH CO., LTD. | Biotechnology | Director/Board Member | |
Yale University | College/University | Doctorate Degree | |
JIANGSU HUALAN NEW PHARMACEUTICAL MATERIAL CO.,LTD. | Containers/Packaging | Director/Board Member | |
Genfleet Therapeutics (Shanghai), Inc.
![]() Genfleet Therapeutics (Shanghai), Inc. Miscellaneous Commercial ServicesCommercial Services Genfleet Therapeutics (Shanghai), Inc. is a Chinese clinical-stage biotechnology company that focuses on developing novel drug candidates for unmet medical needs in oncology and immunology. The company is based in Shanghai, China, and was founded in 2017 by Jiong Lan and Qiang Lü. The company has built up industry-leading capabilities and expertise in developing both small molecules and biologics since its inception in 2017. Genfleet's proprietary and fully integrated R&D platform highlights multiple cutting-edge products with novel mechanisms and IP. The company's pipeline includes over 10 programs, many of which have entered multi-regional clinical trials across China. Genfleet has completed co-development partnerships with a number of publicly listed companies worldwide. Jiong Lan has been the CEO since 2017. | Miscellaneous Commercial Services | Director/Board Member | |
Innolake Pharmaceuticals (Hangzhou) Co., Ltd.
![]() Innolake Pharmaceuticals (Hangzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Innolake Pharmaceuticals (Hangzhou) Co., Ltd. is a company based in Hangzhou, China that engages in the development and commercialization of therapeutic drugs for tumors and immune system diseases. The Chinese company was founded in 2020 by Ru Lei Chen and Ming De Xia, with Ming De Xia serving as the CEO since 2020. | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
China | 5 |
Verenigde Staten | 2 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Process Industries | 2 |
Commercial Services | 2 |
Operationeel
Director/Board Member | 8 |
Chief Executive Officer | 1 |
Chairman | 1 |
Doctorate Degree | 1 |
Independent Dir/Board Member | 1 |
Sterkste connecties
Insiders | |
---|---|
Dan Liu | 6 |
Qing Song Sheng | 1 |
Qing Zhong Tan | 1 |
Zeng Jiao Sui | 1 |
Yun Feng | 1 |
- Beurs
- Insiders
- Jing Jiang
- Bedrijfsconnecties